[1]
Sacchi, V. 2008. Daptomycin (Cubicin) in patients with complicated skin or soft-tissue infections. Farmeconomia. Health economics and therapeutic pathways. 9, 3 (Sep. 2008), 163–166. DOI:https://doi.org/10.7175/fe.v9i3.229.